Login / Signup

Plasma Membrane Channel TRPM4 Mediates Immunogenic Therapy-Induced Necrosis.

Santanu GhoshRachel YangDarjan DurakiJunyao ZhuJi Eun KimMusarrat JabeenChengjian MaoXinyi DaiMara R LivezeyMatthew W BoudreauBen Ho ParkErik Russell NelsonPaul J HergenrotherDavid J Shapiro
Published in: Cancer research (2023)
A genome-wide CRISPR screen reveals a pivotal role for TRPM4 in cell death and immune activation following treatment with diverse necrosis-inducing anticancer therapies, which could facilitate development of necrosis-based cancer immunotherapies.
Keyphrases